What happened in this Tech story?

The OpenAI Foundation launched a "Public Data for Health" initiative to bankroll scientific datasets for medical AI, including $40 million for cancer vaccine data at UNC Chapel Hill and a $500,000 grant to 1Day Sooner to acquire bankrupt biotechs' regulatory filings.

What is a key fact in this story? (1)

**OpenAI Foundation** launched "Public Data for Health," with $40 million going to the University of North Carolina, Chapel Hill for novel cancer vaccine data and additional support for OpenAdmet, which runs drug-effect prediction competitions.

What is a key fact in this story? (2)

**1Day Sooner** received a $500,000 grant to pursue policy analyst Ruxandra Teslo's idea of acquiring "common technical documents" — regulatory filings containing the full back-and-forth between companies and the FDA — from bankrupt biotechs as AI training material.

📎 SkimNews has covered OpenAI 465+ times · see the file →

OpenAI Foundation Funds Medical AI Data Push — SkimNews

By MIT Technology Review · Summarized & edited by Kapil Samant · 2026-09-15

Get the Tech newsletter

Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.

OpenAI Foundation launched "Public Data for Health," with $40 million going to the University of North Carolina, Chapel Hill for novel cancer vaccine data and additional support for OpenAdmet, which runs drug-effect prediction competitions.
1Day Sooner received a $500,000 grant to pursue policy analyst Ruxandra Teslo's idea of acquiring "common technical documents" — regulatory filings containing the full back-and-forth between companies and the FDA — from bankrupt biotechs as AI training material.
1Day Sooner already holds three datasets, two donated by Lumen Bioscience, though two other acquisition bids this year were rejected; president Josh Morrison says nonexclusive copies could be obtained for "a few tens of thousands of dollars" each.
The OpenAI Foundation holds a 26% equity stake in OpenAI, potentially making it the world's wealthiest charity at roughly $250 billion in stock value, and foundation executive Jacob Trefethen says it aims to give away $1 billion by year-end.
The foundation's largest prior gift was $100 million in August to the Common Health Coalition for hepatitis C drug access, even as key foundation roles remain unfilled and grantmaking only began ramping up this year.
The article frames bankruptcy data grabs as a potential "new land grab" for AI training, citing Google's recent winning bid for Spirit Airlines' corporate data including 100 million emails — a model the OpenAI Foundation is now funding in biotech.

Why it matters: The $1 billion annual giving target is rounding-error money against the foundation's $250 billion potential stake, so its willingness to spend on acquiring bankrupt biotechs' FDA filings signals a new funding playbook for feeding medical AI. Smaller failed biotechs could now have their clinical trial data scooped up cheaply and fed to foundation-backed models, with no mechanism for regulators, patients, or rival researchers to weigh in on how those proprietary files get repurposed.